IL18 and type 2 diabetes mellitus: The amplitude, as well as the duration of OPGLTT-induced response of several inflammation markers, including IL-6, IL-18 and TNF-α, was reported to be augmented in T2DM patients compared to healthy subjects (Esposito et al. 2003; Nappo et al. 2002).